Learn more

LAGUNA PHARMACEUTICALS INC

Overview
  • Total Patents
    15
  • GoodIP Patent Rank
    121,723
About

LAGUNA PHARMACEUTICALS INC has a total of 15 patent applications. Its first patent ever was published in 2011. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals, measurement and organic fine chemistry are BELARDINELLI LUIZ, IMMEDICA PHARMA AB and CAN FITE BIOPHARMA LTD.

Patent filings in countries

World map showing LAGUNA PHARMACEUTICALS INCs patent filings in countries

Patent filings per year

Chart showing LAGUNA PHARMACEUTICALS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Brown Arthur M 14
#2 Dittrich Howard C 7
#3 Khosla Rajesh K 2
#4 Khosla Rajesh 2
#5 Arthur M Brown 1
#6 Howard C Dittrich 1
#7 Rajesh Khosla 1

Latest patents

Publication Filing date Title
WO2014176572A2 Pharmaceutical compositions comprising vanoxerine and methods of use for loading phase and chronic administration
US2016304477A1 Novel metabolites of vanoxerine compounds, pharmaceutical compositions containing the same and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm in mammals
AU2014256878A1 Vanoxerine for self-administration for terminating acute episodes of cardiac arrhythmia in mammals
WO2014176567A2 Pharmaceutical compositions comprising vanoxerine and antianginal compounds, and methods of administration of the same for treating episodes of cardiac arrhythmia, maintaining normal sinus rhythm, preventing recurrence of cardiac arrhythmia, and treatment of chronic cardiac arrhythmia in mammals
US2016303114A1 Pharmaceutical compositions containing vanoxerine and p450 inhibitors and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rythym in mammals through administration of said compositions
AU2014256899A1 Methods of administration of single doses of vanoxerine to terminate acute episodes of cardiac arrhythmia